CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...

BioStem Technologies offers strong YoY growth, profitability, and innovation in regenerative medicine. Read more to see why ...

Adia Nutrition, Inc. (OTCQB: ADIA), a pioneer in regenerative medicine and nutritional supplements, is excited to announce the addition of licensing agreements to its business model, driven by strong ...

The regenerative medicine market is an exciting and rapidly evolving sector within the healthcare industry. This market focuses on the development and application of therapies and technologies ...

The Tissue Engineered Skin Substitute Market is projected to be worth USD 2.4 billion in 2024. The market is anticipated to reach USD 3.5 billion by 2034. The market is further expected to surge at a ...

The FDA has since approved multiple T-cell therapy products, including those with transgenic ... Stem cell therapy, or ...

VTV.vn - Biotechnology is increasingly affirming its crucial role in improving public health and quality of life. In Viet Nam ...

Alcon posts steady growth in Vision Care and Surgical, with new drug and therapy launches ahead but execution risks persist.

Highlights the unique potential of Celularity’s proprietary advanced biomaterial technology as a novel cellular delivery system for ocular surface reconstruction Supports broad range of regenerative ...

From portable mirrors to spa facials and cosmetics, shop our beauty savings. Don't miss exclusive discounts up to 50% off.

The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells.